Association between duration of neoadjuvant hormonal therapy and prostate-specific antigen response and pathological outcomes in high-risk prostate cancer undergoing robot-assisted radical prostatectomy.
Saved in:
| Title: | Association between duration of neoadjuvant hormonal therapy and prostate-specific antigen response and pathological outcomes in high-risk prostate cancer undergoing robot-assisted radical prostatectomy. |
|---|---|
| Authors: | Wang J; The First Affiliated Hospital of Soochow University, Department of Urology, Suzhou, Jiangsu, China., Wu Y; The First People's Hospital of Jintan, Department of Urology, Changzhou, Jiangsu, China., Zhang C; The First Affiliated Hospital of Soochow University, Department of Urology, Suzhou, Jiangsu, China., Ouyang J; The First Affiliated Hospital of Soochow University, Department of Urology, Suzhou, Jiangsu, China., Zhang F; The First Affiliated Hospital of Soochow University, Department of Nephrology, Suzhou, Jiangsu, China., Zhang Z; The First Affiliated Hospital of Soochow University, Department of Urology, Suzhou, Jiangsu, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Apr 20; Vol. 16, pp. 1817402. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1817402 |
